In the light of present knowledge there appear to be two kinds of hyaluronidase inhibition by blood serum. One inhibitor of hyaluronidase has been demonstrated in the serum or plasma of various normal, nonimmunized animals and man (1) (2) (3) (4) (5) (6) . Haas has reported that this inhibitor is not specific for any particular hyaluronidase, and that it is not an antibody but is an enzyme (3) . However, recently Hadidian and Pirie have, favored the impression that this inhibitor is analogous to an antitoxin or an antibody (5) , and Dorfman, Ott, and Whitney have presented evidence (6) which contests some details of the report of Haas (3) . The findings of Dorfman, Ott, and Whitney lend no support to the thesis that this inhibitor is an enzyme, and leave open the question as to whether or not this inhibitor in normal serum specifically antagonizes particular hyaluronidases (6) . The other inhibitor of hyaluronidase has been demonstrated in the serum of rabbits which had been immunized with a purified hyaluronidase preparation (7) (8) (9) (10) (11) . This inhibitor in immune serum specifically antagonizes the particular hyaluronidase which was used as the antigen; it is developed by an immune response to an antigenic stimulus and may be called an antihyaluronidase.
The inhibitor of hyaluronidase in normal, nonimmune serum is thermolabile (3, 5, 6) , whereas the antihyaluronidase of immune serum is thermostable (12) .
A previous study demonstrated rises in titer of serum antihyaluronidase antagonistic to pneumococcus hyaluronidase in human patients following pneumococcus bacteremia (12) (13) (14) , and some inhibition of pneumococcus hyaluronidase by the serum of every one of 50 normal human beings tested (12, 13) . Only relatively low dilutions of normal sera inhibited the pneumococcus hyalu- 1 Supported by a gift in the memory of the late Ben L.
Heidingsfeld, and by a grant from the Smith, Kline, and French Laboratories, Philadelphia, Pa. ronidase, whereas relatively high dilutions of patients' sera at the peak of immune response inhibited the pneumococcus hyaluronidase (12) . The present study demonstrates that this immune response of human antihyaluronidase serum is specifically antagonistic to the hyaluronidase of the particular species of organism from which the immunizing material was derived (15 The constant amount of each hyaluronidase used throughout these tests was 0.25 cc. of the unrefined hyaluronidase which had been diluted so that either a 1: 8 or a 1: 16 dilution prevented the mucoprotein clot, regardless of the original potency of the hyaluronidase preparation used. The constant amount of the bacterial hyaluronidases was essentially equivalent to the constant amount of the purified bovine testicular hyaluronidase, which contained 0.0013 mgm. of the purified hyaluronidase. This dilution of each hyaluronidase was freshly prepared each day that tests were done. All dilutions of hyaluronidase and of serum to be tested were made in 1%o proteose peptone in physiologic saline.
Serum antihyaluronidase was determined in exactly the same way as described in the previous study (12) , but the description is repeated here for convenience. All of the sera in one patient's series of sera were tested at one time with one hyaluronidase preparation. Twofold serial dilution, beginning with 1: 2, was made for each serum tested. Twelve dilutions, each in the volume of 0.5 cc. in tubes 100 mm. X 13 mm., were made for each serum. The constant amount of hyaluronidase in the volume of 025 cc. was added to each serum dilution, and to a control tube containing 0.5 cc. of proteose peptone saline with no serum. The final dilution of serum in the first tube was 1: 3, and the final volume in each tube was 0.75 cc. These tubes were mixed by shaking the tube rack, then incubated at room temperature (25°C.) for 20 minutes.
Residual hyaluronidase activity which remained after incubation of the serum dilution and hyaluronidase mixtures was determined as follows:
(1) 1.0 cc. of substrate was added to each tube. This substrate contained equal volumes of three components: dialysed tryptic digest of umbilical cord which contained approximately 0.20% hyaluronic acid (17) , normal horse serum (Lederle) which exhibited neither hyaluronidase nor antihyaluronidase activity, and distilled water.
(2) The tubes were mixed by shaking the tube rack, then incubated in a water bath at 370 C. for 30 minutes, and then cooled in an ice water bath for five minutes.
(3) 1.0 cc. of 5% glacial acetic acid was added to each tube, and each tube was shaken individually and read for formation of the mucoprotein clot. The highest dilution of a given serum which exhibited either heavy or thready clot was taken as the antihyaluronidase titer of that serum. Results were expressed in terms of dilution of serum prior to addition of the substrate. Activity of the constant amount of hyaluronidase was demonstrated in the control tube by prevention of the clot.
This mucoprotein clot-prevention test permitted a twofold chance variation of antihyaluronidase titer, but a fourfold chance variation did not occur (12) .
RESULTS
The antihyaluronidase responses obtained in three patients with pneumonia and bacteremia are 5 These dilutions represent essentially equivalent hyaluronidase activity within the accuracy of the test. The antihyaluronidase responses obtained in three patients with empyema and bacteremia are illustrated in Table II . Sera of the first patient exhibited rises of antihyaluronidase titer which were 64-fold or greater as tested with the three pneumococcus hyaluronidases, but no antagonism The antihyaluronidase responses obtained in two other patients are shown in Table III . The first of these patients had Type 12 pneumococcic aortic endocarditis with bacteremia and the second patient had Hemolytic Staphylococcus aureus bacteremia complicating gastric ulcer. Sera of the endocarditis patient exhibited 64-fold rise of antihyaluronidase titer as tested with the Type 2 Pneumococcus hyaluronidase, but no rise of titer as tested with the staphylococcus, streptococcus and C1. Welchii hyaluronidases. Sera of the patient with staphylococcus bacteremia exhibited eightfold rise of antihyaluronidase titer as tested with the staphylococcus hyaluronidase, elaborated by the organism cultured from this patient's blood, but no significant rise of titer as tested with the pneumococcus and Cl. Welchii hyaluronidases. Too much time elapsed between the two sera which were tested with streptococcus hyaluronidase so that no conclusion can be drawn, but the results suggest that there was no rise in titer of antihyaluronidase antagonistic to the streptococcus hyaluronidase.
The antihyaluronidase responses obtained in two patients with repeatedly positive blood culture due to gram negative bacilli are illustrated in Table  IV . The first patient had typhoid fever6f which began about October 7, 1947 , and the second patient had B. coli bacteremia of undetermined origin with onset of illness about October 2, 1947. Sera of both of these patients exhibited no rise of antihyaluronidase titer as tested with Type 2 Pneumococcus, staphylococcus, streptococcus and C1. Welchii hyaluronidases. The second patient's sera exhibited an unusually high titer of antihyaluronidase as tested with C1. Welchii hyaluronidase, for which no explanation is apparent. (10, 11) . The lack of specificity for pneumococcus type exhibited by the antihyaluronidase response in patients with pneumococcus bacteremia has been reported previously (12) (13) (14) .
These findings agree in principle with those of Friou and Wenner (18) on the specific inhibition of hemolytic streptococcus hyaluronidase by the serum of patients with hemolytic streptococcus infedion, but do not support their impression that the streptococcus hyaluronidase is the only hyaluronidase which may be specifically inhibited by human serum. The immune serum antihyaluronidase reported here in patients with pneumococcus bacteremia has been reported previously to be thermostable; it is unaffected by heating at 560 C. for one hour in a water bath (12) . The hyaluronidase inhibitor of normal, non-immune serum has been reported to be thermolabile (3, 5, 6) . This study provides no evidence as to whether or not the hyaluronidase inhibitor of normal, non-immune serum specifically antagonizes a particular hyaluronidase.
SUMMARY
Series of sera from patients who suffered bacteremia due to pneumococcus, staphylococcus, B. typhosus, and B. Coli communis, were tested for antihyaluronidase against equivalent amounts of pneumococcus, staphylococcus, beta Hemolytic Streptococcus, Cl. 'Welchii, and purified bovine testicular hyaluronidase. Patients with pneumococcus bacteremia exhibited rises in titer of serum antihyaluronidase antagonistic to pneumococcus hyaluronidase, but no rise in titer of antihyaluronidase antagonistic to the other hyaluronidases. One patient with Hemolytic Staphylococcus aureus bacteremia exhibited rise in titer of serum antihyaluronidase antagonistic to hyaluronidase elaborated by the same staphylococcus, but no rise in titer of antihyaluronidase antagonistic to pneumococcus and Cl. Welchii hyaluronidases.
CONCLUSION
In human beings immunized by an infection which elaborates hyaluronidase the immune serum antihyaluronidase is specifically antagonistic to the hyaluronidase of the particular species of organism from which the antigen was derived, so far as the pneumococcus is concerned. This finding probably applies to the staphylococcus, and to other species of organisms which elaborate hyaluronidase.
